Training

2nd Masterclass, 2021, Leuven

The Training section offers information on MICROB-PREDICT training and education activities for early career researchers interested in any of the scientific fields of MICROB-PREDICT.

Educational material for download

• Clinical insights for biologists (Prof. Debbie Shawcross, Kings College London) (PDF | 4.67 MB)
• Omics for clinicians (Dr Christophe Junot, CEA) (PDF | 3.99 MB)

MICROB-PREDICT Poster Session

General Assembly Meeting, October 2021, Leuven/Belgium

• Better safe than sorry; RNA extraction method selection for salivary metatranscriptomics
  (Romy Zwittink, LUMC) (PDF | 268 KB)
• Effect of Rifaximin on gut microbiota in experimental liver fibrosis
  (Sabine Klein, University Hospital Frankfurt) (PDF | 1.11 MB)
• Faecal Microbiota Transplantation To Tackle Antimicrobial Resistance in Chronic Liver Disease
  (Lindsey Edwards, Kings College London) (PDF | 732 KB)
• Fecal virome in decompensated liver cirrhosis patients
  (Lore Van Espen, KU Leuven) (PDF | 5.16 MB)
• From biomarkers to biosensors: an unexpected journey
  (Giulio Rosati, ICN2) (PDF | 824 KB)
• Generation of rat models of acute decompensation of cirrhosis developing ACLF
  (Sabine Klein, University Hospital Frankfurt) (PDF | 2.03 MB)
• Gut immunity and integrity markers in acute on chronic liver failure
  (Dávid Tornai, University of Debrecen) (PDF | 4.35 MB)
• JANUS KINASE 2 INHIBITION BY PACRITINIB IS A POTENTIAL THERAPEUTIC TARGET FOR LIVER FIBROSIS AND PORTAL HYPERTENSION
  (Sabine Klein, University Hospital Frankfurt) (PDF | 3.63 MB)
• Longitudinal metabolomics investigations of blood, urine and fecal matrices for the stratification of cirrhotic patients with acute on chronic liver failure (ACLF)
  (Christophe Junot, CEA) (PDF | 1.10 MB)
• MUCOSA-PREDICT Clinical Data Reformatting for Analysis
  (Florence Servant, Vaiomer) (PDF | 1.06 MB)
• Potential mechanisms underlying the protective effect of long-term albumin infusion in cirrhosis
  (Alexandra Philipps, University College London) (PDF | 988 KB)
• Salivary microbiome biomarkers predicting the response to albumin treatment
  (Manolo Laiola, INRAE – MetaGenoPolis) (PDF | 290 KB)
• The oral metabolome and microbiome as risk factors for developing type 2 diabetes
  (Casper Poulsen, University of Copenhagen) (PDF | 779 KB)
• The trial design of PROMISE – A PROspective double-blind placebocontrolled multicentre trial of faecal MIcrobiota tranSplantation to improve outcomEs in patients with cirrhosis
  (Victoria Kronsten, Kings College London) (PDF | 2.81 MB)

MICROB-PREDICT Poster Award

Congratulations to Marisa Metzger (EMBL) for winning the first prize of the MICROB-PREDICT Poster Award 2021.

We also would like to congratulate our other winners: Lore Van Espen, KU Leuven (2nd prize) and Manolo Laiola, INRAE – MetaGenoPolis (3rd prize).

Prof. Dr. Jonel Trebicka (MICROB-PREDICT Coordinator) and Dr Benjamin Lelouvier (Chair of the MICROB-PREDICT Impact Board) with the lucky winners (from left to right: Marisa Metzger, Lore Van Espen, Manolo Laiola).